{"id":"NCT01263132","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"Neuropathic Pain Management","officialTitle":"Neuropathic Pain Treatment Using F0434 vs. Gabapentin in Patients With Chronic Distal Diabetic Polyneuropathy: A Randomized, Controlled, Double-blind Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2010-02","completion":"2010-02","firstPosted":"2010-12-20","resultsPosted":"2011-10-27","lastUpdate":"2014-02-13"},"enrollment":104,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Neuropathies","Polyneuropathies"],"interventions":[{"type":"DRUG","name":"F0434","otherNames":["Gabapentin with thiamine and cobalamin"]},{"type":"DRUG","name":"Gabapentin","otherNames":["Gababion","Gavindo"]}],"arms":[{"label":"F0434","type":"EXPERIMENTAL"},{"label":"Gabapentin","type":"ACTIVE_COMPARATOR"}],"summary":"This is a prospective, randomized, double blind, comparative, experimental controlled Phase 3 clinical trial to assess the efficacy, safety and superiority of F0343 (gabapentin combined with B vitamins) compared to gabapentin alone for treating neuropathic pain in subjects with chronic distal diabetic polyneuropathy.","primaryOutcome":{"measure":"Mean Neuropathic Pain Score at Visit 3 (Week 1)","timeFrame":"Visit 3 (Week 1)","effectByArm":[{"arm":"Gabapentin","deltaMin":51,"sd":17.39},{"arm":"MF0434 + Gabapentin","deltaMin":50.7,"sd":16.67}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":12},"locations":{"siteCount":1,"countries":["Mexico"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":38},"commonTop":["Dizziness","Drowsiness","Headache","Hypoglycemia","Lower Limb Edema"]}}